Evidence map›Paper›PMID 25109669›Full record

ArticleExperimental neurology2014

The first knockin mouse model of episodic ataxia type 2.

Samuel J Rose, Lisa H Kriener, Ann K Heinzer, Xueliang Fan, Robert S Raike, Arn M J M van den Maagdenberg, Ellen J Hess

Abstract read
In one paragraph

Article in Experimental neurology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Voltage-Gated CaFrontiers in synaptic neuroscience · 2021
    Review
  8. Rare CACNA1A mutations leading to congenital ataxia.Pflugers Archiv : European journal of physiology · 2020
    Review
  9. Zebrafish as a Model System for the Study of Severe CaFrontiers in molecular neuroscience · 2019
    Review
  10. Ubiquitin Ligase RNF138 Promotes Episodic Ataxia Type 2-Associated Aberrant Degradation of Human CaThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2017
    Article
  11. Article
  12. A new knock-in mouse model of l-DOPA-responsive dystonia.Brain : a journal of neurology · 2015
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Samuel J RoseDepartment of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Lisa H KrienerDepartment of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Ann K HeinzerDepartment of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Xueliang FanDepartment of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Robert S RaikeDepartment of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Arn M J M van den MaagdenbergDepartment of Human Genetics, Leiden University Medical Centre, 2300 RC Leiden, The Netherlands; Department of Neurology, Leiden University Medical Centre, 2300 RC Leiden, The Netherlands.
Ellen J HessDepartment of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322, USA; Department of Neurology, Emory University School of Medicine, Atlanta, GA 30322, USA. Electronic address: ellen.hess@emory.edu.
Emory University · USJohns Hopkins Medicine · USLeiden University Medical Center · NL

Funding

TRAINING IN TRANSLATIONAL RESEARCH IN NEUROLOGYT32NS007480 · NINDS · EMORY UNIVERSITY · PI LEVEY, ALLAN I · 2000 to 2020
$4.5M
TRAINING IN SYSTEMS AND INTEGRATIVE BIOLOGY:NEUROSCIENCET32GM008605 · NIGMS · EMORY UNIVERSITY · PI SMITH, YOLAND · 1996 to 2015
$4.2M
Pathophysiology of dystonia: animal modelsR01NS033592 · NINDS · JOHNS HOPKINS UNIVERSITY · PI HESS, ELLEN J. · 2001 to 2010
$3.5M
Generation of a mouse model of episodic ataxia type 2 (EA2)R21NS058596 · NINDS · JOHNS HOPKINS UNIVERSITY · PI HESS, ELLEN J. · 2007 to 2008
$395k
MOLECULAR BASIS OF THE TOTTERING PHENOTYPER29NS033592 · NINDS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI HESS, ELLEN J. · 1995 to 1999
–
NIGMS NIH HHS T32 GM008605NIGMS NIH HHS T32GM08605NINDS NIH HHS NS058596NINDS NIH HHS NS33592NINDS NIH HHS R01 NS033592NINDS NIH HHS R21 NS058596NINDS NIH HHS R29 NS033592NINDS NIH HHS T32 NS007480NINDS NIH HHS T32NS007480
6 · The paper itself

Abstract

Episodic ataxia type 2 (EA2) is an autosomal dominant disorder associated with attacks of ataxia that are typically precipitated by stress, ethanol, caffeine or exercise. EA2 is caused by loss-of-function mutations in the CACNA1A gene, which encodes the α1A subunit of the CaV2.1 voltage-gated Ca(2+) channel. To better understand the pathomechanisms of this disorder in vivo, we created the first genetic animal model of EA2 by engineering a mouse line carrying the EA2-causing c.4486T>G (p.F1406C) missense mutation in the orthologous mouse Cacna1a gene. Mice homozygous for the mutated allele exhibit a ~70% reduction in CaV2.1 current density in Purkinje cells, though surprisingly do not exhibit an overt motor phenotype. Mice hemizygous for the knockin allele (EA2/- mice) did exhibit motor dysfunction measurable by rotarod and pole test. Studies using Cre-flox conditional genetics explored the role of cerebellar Purkinje cells or cerebellar granule cells in the poor motor performance of EA2/- mice and demonstrate that manipulation of either cell type alone did not cause poor motor performance. Thus, it is possible that subtle dysfunction arising from multiple cell types is necessary for the expression of certain ataxia syndromes.

Indexed as

AnimalsAtaxiaCalcium Channel BlockersCalcium Channels, N-TypeCerebellumDisease Models, AnimalHumansIntracellular Signaling Peptides and ProteinsMembrane PotentialsMiceMice, Inbred C57BLMice, TransgenicMotor ActivityMutation, MissenseNeuronsNystagmus, PathologicCalcium Channel BlockersCalcium Channels, N-TypeIntracellular Signaling Peptides and ProteinsSH3GL1 protein, humanSodium Channel BlockersTetrodotoxinAtaxiaCACNA1ACerebellar granule cellChannelopathyCreEA2Episodic ataxia type 2KnockinPurkinje cellVoltage-gated calcium channel

Identifiers

PMID25109669
PMCPMC4194266
OpenAlexW2010427272

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.